Abstract
We review the results of experimental and clinical observations on neoangiogenesis in patients with breast cancer. Vascular endothelial growth factor is an important positive regulator of this process. Experiments showed the possibility of using various direct and indirect antiangiogenic means in the therapy of breast cancer, but clinical efficiency of these methods was not proved. Expression of vascular endothelial growth factor can serve as a prognostic criterion in breast cancer. Antiangiogenic preparations should not be used as monotherapy, but as the treatment complementary to standard therapy.
Similar content being viewed by others
REFERENCES
J. Adams, P. J. Carder, S. Downey, et al.I, Cancer Res., 60,No. 11, 2898–2905 (2000).
K. Anan, T. Morisaki, M. Katano, et al., Surgery, 119,No. 3, 333–339 (1996).
K. Anan, T. Morisaki, M. Katano, et al., Eur. J. Surg. Oncol., 24,No. 1, 28–33 (1998).
M. Asano, A. Yukita, and H. Suzuki, Jpn. J. Cancer Res., 90,No. 1, 93–100 (1999).
A. Biroccio, A. Candiloro, and M. Mottolese, FASEB J., 14,No. 5, 652–660 (2000).
C. Blancher, J. W. Moore, N. Robertson, and A. L. Harris, Cancer Res., 61,No. 19, 7349–7355 (2001).
P. Borgstrom, D. P. Gold, K. J. Hillan, and N. Ferrara, Anticancer Res., 19,No. 5B, 4203–4214 (1999).
R. Bos, H. Zhong, C. F. Hanrahan, et al., J. Natl. Cancer Inst., 93,No. 4, 309–314 (2001).
L. F. Brown, A. J. Guidi, S. J. Schnitt, et al., Clin. Cancer Res., 5,No. 5, 1041–1056 (1999).
G. Callagy, E. Dimitriadis, J. Harmey, et al., Appl. Immunohistochem. Mol. Morphol., 8,No. 2, 104–109 (2000).
F. Ciardiello, R. Caputo, R. Bianco, et al., Clin. Cancer Res., 7,No. 5, 1459–1465 (2001).
D. Coradini, P. Boracchi, M. G. Daidone, et al., Br. J. Cancer, 85,No. 6, 795–797 (2001).
J. S. De Jong, P. J. van Diest, P. van der Valk, and J. P. Baak, J. Pathol., 184,No. 1, 44–52 (1998).
J. S. De Jong, P. J. van Diest, P. van der Valk, and J. P. Baak, Ibid., 184,No. 1, 53–57 (1998).
I. Ding, J. Z. Sun, B. Fenton, and W. M. Liu, Cancer Res., 61,No. 2, 526–531 (2001).
L. Y. Dirix, P. B. Vermeulen, A. Pawinski, et al., Br. J. Cancer, 76,No. 2, 238–243 (1997).
D. Donovan, J. H. Harmey, D. Toomey, et al., Ann. Surg. Oncol., 4,No. 8, 621–627 (1997).
T. Eisen, C. Boshoff, I. Mak, et al., Br. J. Cancer, 82,No. 4, 812–817 (2000).
U. Eppenberger, W. Kueng, J. M. Schlaeppi, et al., J. Clin. Oncol., 16,No. 9, 3129–3136 (1998).
N. Ferrara, Breast Cancer Res. Treat., 36,No. 2, 127–137 (1995).
J. A. Foekens, H. A. Peters, and N. Grebenchtchikov, Cancer Res., 61,No. 14, 5407–5414 (2001).
J. Folkman, Harrison's textbook of internal medicine, 15th ed., Eds. E. Braunwald, et al. New York (2001), p. 517–530.
G. Gasparini, Crit. Rev. Oncol. Hematol., 37,No. 2, 97–114 (2001).
G. Gasparini, Oncologist., 5,Suppl. 1, 37–44 (2000).
G. Gasparini, M. Toi, E. Biganzoli, et al., Oncology, 60,No. 1, 72–80 (2001).
G. Gasparini, M. Toi, M. Gion, et al., J. Natl. Cancer Inst., 89,No. 2, 139–147 (1997).
G. Gasparini, M. Toi, R. Miceli, et al., Cancer J. Sci. Am., 5,No. 2, 101–111 (1999).
R. R. Greb, I. Maier, D. Wallwiener, and L. Kiesel, Br. J. Cancer, 81,No. 2, 225–231 (1999).
A. J. Guidi, S. J. Schnitt, L. Fischer, et al., Cancer, 80,No. 10, 1945–1953 (1997).
A. L. Harris, Recent Results Cancer Res., 152, 341–352 (1998).
A. L. Harris, H. Zhang, A. Moghaddam, et al., Breast Cancer Res. Treat., 38,No. 1, 97–108 (1996).
K. Heer, H. Kumar, V. Speirs, et al., Br. J. Cancer, 78,No. 9, 1203–1207 (1998).
S. M. Hyder, L. Murthy, and G. M. Stancel, Cancer Res., 58,No. 3, 392–395 (1998).
S. M. Hyder, Z. Nawaz, C. Chiappetta, and G. M. Stancel, Ibid., 60,No. 12, 3183–3190 (2000).
S. M. Hyder and G. M. Stancel, Histol. Histopathol., 15,No. 1, 325–334 (2000).
S. M. Hyder, C. Chiappetta, and G. M. Stancel, Int. J. Cancer, 92,No. 4, 469–473 (2001).
S. A. Im, J. S. Kim, C. Gomez Manzano, et al., Br. J. Cancer, 84,No. 9, 1252–1257 (2001).
C. Iwasaka, K. Tanaka, M. Abe, and Y. Sato, J. Cell Physiol., 169,No. 3, 522–531 (1996).
R. S. Kerbel, Cancer Res., 61,No. 13, 5090–5101 (2001).
R. S. Kerbel, A. Viloria Petit, G. Klement, and J. Rak, Eur. J. Cancer, 36,No. 10, 1248–1257 (2000).
N. Klauber, S. Parangi, E. Flynn, et al., Cancer Res., 57,No. 1, 81–86 (1997).
A. Kraft, K. Weindel, A. Ochs, et al., Cancer, 85,No. 1, 178–187 (1999).
A. Kranz, T. Mattfeldt, and J. Waltenberger, Int. J. Cancer, 84,No. 3, 293–298 (1999).
J. Kurebayashi, T. Otsuki, H. Kunisue, et al., Jpn. J. Cancer Res., 90,No. 9, 977–981 (1999).
J. Kurebayashi, H. Kunisue, S. Yamamoto, et al., Oncology, 59,No. 2, 158–165 (2000).
D. H. Lau, L. Xue L., J. Young, et al., Cancer Biother. Radiopharm., 14,No. 1, 31–36 (1999).
E. Laughner, P. Taghavi, K. Chiles, et al., Mol. Cell Biol., 21,No. 12, 3995–4004 (2001).
A. H. Lee, E. A. Dublin, L. G. Bobrow, and R. Poulsom, J. Pathol., 185,No. 4, 394–401 (1998).
R. D. Leek, N. C. Hunt, R. J. Landers, et al., Ibid., 190,No. 4, 430–436 (2000).
H. C. Lichtenbeld, A. F. Barendsz-Janson, H. van Essen, et al., Int. J. Cancer, 77,No. 3, 455–459 (1998).
B. Linderholm, K. Grankvist, N. Wilking, et al., J. Clin. Oncol., 18,No. 7, 1423–1431 (2000).
B. Linderholm, B. Lindh, B. Tavelin, et al., Int. J. Cancer, 89,No. 1, 51–62 (2000).
B. Linderholm, B. Tavelin, K. Grankvist, and R. Henriksson, Br. J. Cancer, 81,No. 4, 727–732 (1999).
P. Lissoni, E. Fugamalli, F. Malugani, et al., Int. J. Biol. Markers, 15,No. 4, 308–311 (2000).
N. Locopo, M. Fanelli, and G. Gasparini, Breast Cancer Res. Treat., 52,Nos. 1–3, 159–173 (1998).
P. Mignatti and D.B. Rifkin, Enzyme Protein, 49, 117–137 (1996).
A. Obermair, E. Kucera, K. Mayerhofer, et al., Int. J. Cancer, 74,No. 4, 455–458 (1997).
T. Ohhashi, Nippon Geka Gakkai Zasshi., 102,No. 6, 435–439 (2001).
G. P. Pidgeon, M. P. Barr, J. H. Harmey, et al., Br. J. Cancer. 85,No. 2, 273–278 (2001).
G. Pintucci, A. Bikfalvi, S. Klein, and D. B. Rifkin, Semin. Thromb. Hemost., 22,No. 6, 517–524 (1996).
M. Relf, S. LeJeune, P. A. Scott, et al., Cancer Res., 57,No. 5, 963–969 (1997).
J. K. Ruohola, E. M. Valve, M. J. Karkkainen, et al., Mol. Cell. Endocrinol., 149,Nos. 1–2, 29–40 (1999).
P. Salven, V. Perhoniemi, H. Tykka, et al., Breast. Cancer Res. Treat., 53,No. 2, 161–166 (1999).
P. Salven, H. Manpaa, A. Orpana, et al., Clin. Cancer Res., 3,No. 5, 647–651 (1997).
Y. Sato, Hum. Cell, 11,No. 4, 207–214 (1998).
P. A. Scott, J. M. Gleadle, R. Bicknell, and A. L. Harris, Int. J. Cancer, 75,No. 5, 706–712 (1988).
P. A. Scott, K. Smith, R. Poulsom, et al., Br. J. Cancer, 77,No. 12, 2120–2128 (1998).
M. Skobe, T. Hawighorst, D. G. Jackson, et al., Nat. Med., 7,No. 2, 192–198 (2001).
V. Speirs and S. L. Atkin, Br. J. Cancer, 80,Nos. 5–6, 898–903 (1999).
M. Toi, S. Hoshina, T. Takayanagi, and T. Tominaga, Jpn. J. Cancer Res., 85,No. 10, 1045–1049 (1994).
M. Toi, K. Inada, S. Hoshina, et al., Clin. Cancer Res., 1,No. 9, 961–964 (1995).
M. Toi, K. Inada, H. Suzuki, and T. Tominaga, Breast Cancer Res. Treat., 36,No. 2, 193–204 (1995).
M. Toi, S. Kondo, H. Suzuki, et al., Cancer, 77,No. 6, 1101–1106 (1996).
M. Toi, Y. Yamamoto, T. Taniguchi, et al., Gan To Kagaku Ryoho, 23,Suppl. 1, 75–79 (1996).
R. Valtola, P. Salven, P. Heikkila, et al., Am. J. Pathol., 154,No. 5, 1381–1390 (1999).
B. Vandenbunder, N. Wernert, C. Queva, et al., Folia Biol. (Praha), 40,No. 5, 301–313 (1994).
G. Wang, Z. Dong, G. Xu, et al., J. Cancer Res. Clin. Oncol., 124,No. 11, 615–620 (1998).
G. Wang, Z. Yang, and C. Shou, Chung Hua Chung Liu Tsa Chih, 19,No. 6, 407–409 (1997).
S. R. Wedge, D. J. Ogilvie, M. Dukes, et al., Cancer Res., 60,No. 4, 970–975 (2000).
B. Xie, N. N. Tam, S. W. Tsao, Y. C. Wong, Br. J. Cancer, 81,No. 8, 1335–1343 (1999).
Y. Yamamoto, M. Toi, S. Kondo, et al., Clin. Cancer Res., 2,No. 5, 821–826 (1996).
L. Yen, X.L. You, A. E. Al Moustafa, et al., Oncogene, 19,No. 31, 3460–3469 (2000).
H. Yoshiji, D. E. Gomez, M. Shibuya, and U. P. Thorgeirsson, Cancer Res., 56,No. 9, 2013–2016 (1996).
B. K. Zebrowski, S. Yano, W. Liu, et al., Clin. Cancer Res., 5,No. 11, 3364–3368 (1999).
H. T. Zhang, P. Craft, P. A. Scott, et al., J. Natl. Cancer Inst., 87,No. 3, 213–219 (1995).
M. Ziche, S. Donnini, L. Morbidelli, et al., Br. J. Cancer, 77,No. 7, 1123–1129 (1998).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kushlinskii, N.E., Gershtein, E.S. Role of Vascular Endothelial Growth Factor during Breast Cancer. Bulletin of Experimental Biology and Medicine 133, 521–528 (2002). https://doi.org/10.1023/A:1020259702427
Issue Date:
DOI: https://doi.org/10.1023/A:1020259702427